Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

147
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
147
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

671
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
671
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

314
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
314
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

393
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
393
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

328
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
328
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

422
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
422

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring Income Inequality Within 8 Health Care Professions in the United States.

Medical care·2026
Same author

Is Pharmacy a Friendly Profession for Everyone in the U.S.? A Probe into Gender and Other Income Disparities.

Pharmacy (Basel, Switzerland)·2025
Same author

Gender and ethnic disparities in students' perceptions of how different groups of persons suspected of possessing and/or selling illegal drugs are treated in the criminal justice system.

Journal of ethnicity in substance abuse·2023
Same author

Nature and Composition of Earnings Reported by Health Economists and Related Professionals: Gender, Education, and job Characteristics Matter.

Health services research and managerial epidemiology·2022
Same author

Gender and Pharmacists' Career Satisfaction in the United States.

Pharmacy (Basel, Switzerland)·2021
Same author

Disparities in the Wage-and-Salary Earnings, Determinants, and Distribution of Health Economics, Outcomes Research, and Market Access Professionals: An Exploratory Study.

PharmacoEconomics - open·2021

Related Experiment Video

Updated: Jan 13, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K

Not All U.S. Pharmacists Are Equal: A Full-Time Versus Part-Time Comparison.

Ioana Popovici1, Manuel J Carvajal1

  • 1Department of Sociobehavioral and Administrative Pharmacy, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL 33328-2018, USA.

Pharmacy (Basel, Switzerland)
|October 28, 2025
PubMed
Summary

Earnings for pharmacists differ significantly based on full-time vs. part-time work. This study reveals distinct factors influencing pharmacist compensation across employment types, impacting workforce planning.

Keywords:
earningsgenderhuman capitalincome gapsjob-related preferenceslabor inputpart-time employmentpharmacist workforce

More Related Videos

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.3K

Related Experiment Videos

Last Updated: Jan 13, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.3K

Area of Science:

  • Health Economics
  • Labor Economics
  • Pharmacy Practice

Background:

  • Part-time employment is growing in the U.S. labor market.
  • Limited research exists on earnings determinants for full-time versus part-time pharmacists.
  • Existing studies often use small or outdated datasets.

Purpose of the Study:

  • To analyze earnings determinants separately for full-time and part-time pharmacists.
  • To compare how work input, human capital, demographics, and job features affect pharmacist pay.
  • To provide timely insights into the current pharmacist labor market.

Main Methods:

  • Utilized data from the 2019-2022 American Community Survey (ACS).
  • Included 12,064 pharmacists aged 25-64 practicing in the U.S.
  • Employed ordinary least-squares regression analysis, stratified by gender and employment type.

Main Results:

  • Identified significant differences in factors influencing earnings between full-time and part-time pharmacists.
  • Demonstrated the interplay of individual choices and market forces on pharmacist compensation.
  • Highlighted variations in the impact of covariates across different employment categories.

Conclusions:

  • Pharmacist earnings are shaped by distinct factors depending on employment status (full-time vs. part-time).
  • Findings underscore the need for tailored strategies to support pharmacist retention and satisfaction.
  • Results inform workforce planning and the design of targeted job incentives.